Zhong Ji Longevity Science Group Limited (HKG:0767)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Money Lending and Financial Advisory Business	24.17M	33.66M	45.75M	38.66M	-
Money Lending and Financial Advisory Business Growth	-28.21%	-26.42%	18.33%	-	-
Longevity Science Business	142.02M	31.33M	43.92M	22.45M	-
Longevity Science Business Growth	353.35%	-28.67%	95.67%	-	-
Securities and Other Investments	-	-	-	13.00K	5.72M
Securities and Other Investments Growth	-	-	-	-99.77%	-61.67%
Unallocated Share of Loss of Joint Ventures	-	-79.00K	-1.63M	900.00K	-1.15M
Money Lending	-	-	-	-	61.15M
Money Lending Growth	-	-	-	-	-49.86%
Financial and Investment Advisory	-	-	-	-	13.15M
Financial and Investment Advisory Growth	-	-	-	-	47.09%
Total	166.18M	64.91M	88.04M	62.02M	78.87M
Total Growth	156.02%	-26.27%	41.96%	-21.36%	-46.31%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Hong Kong	118.01M	15.16M	14.66M	15.50M	48.08M
Hong Kong Growth	678.53%	3.42%	-5.46%	-67.76%	-43.63%
Mainland China of the PRC	48.17M	49.83M	75.01M	45.62M	31.94M
Mainland China of the PRC Growth	-3.33%	-33.57%	64.44%	42.81%	-47.25%
Total	166.18M	64.99M	89.67M	61.12M	80.02M
Total Growth	155.71%	-27.52%	46.71%	-23.62%	-45.13%

Source: S&P Global Market Intelligence.